The Singapore Exchange (SGX) has announced the divestment of its wholly owned subsidiary, Scientific Beta, to global index provider STOXX for approximately €23 million (US$26.2 million). This move is part of SGX's strategy to focus on its core growth areas and redeploy resources accordingly. SGX acquired a majority stake in Scientific Beta in 2020 and completed full ownership in 2025. The proceeds from the sale will be used for general working capital purposes. SGX will continue to operate and develop its existing index business through its global multi-asset iEdge platform. Scientific Beta, established in 2012 by the EDHEC-Risk Institute, specializes in multi-factor, single-factor, and diversified equity strategies. The company has experienced recent financial challenges, reporting a net loss of approximately S$15 million in the first half of the fiscal year 2026. Following the divestment, Scientific Beta is expected to expand its global reach under its new ownership. SGX's shares closed at S$24.01 on Wednesday, down S$0.16 or 0.7 percent.
News From Multiple Perspectives
SGX divests index provider Scientific Beta
Published July 8, 2026 at 1:15 PM UTC